MetaADEDB 2.0 @ LMMD
Cholic Acid
(BHQCQFFYRZLCQQ-OELDTZBJSA-N)
Structure
SMILES
O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2C[C@H](O)[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C
Type(s)
Approved
ATC code(s)
A05AA03
Molecular Formula:
C24H40O5
Molecular Weight:
408.571
Log P:
3.4487
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
4
TPSA:
97.99
CAS Number(s):
81-25-4
Synonym(s)
1.
Cholic Acid
2.
Acid, Cholic
External Link(s)
MeSHD019826
PubChem Compound221493
BindingDB50236237
21680
ChEBI16359
CHEMBLCHEMBL205596
DrugBankDB02659
DrugCentral3096
IUPHAR/BPS Guide to PHARMACOLOGY609
KEGGcpd:C00695
dr:D10699
Therapeutic Target DatabaseD0OR2L
ZINC6858022
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainFAERS: 3US FAERS
2AscitesFAERS: 3US FAERS
3ConstipationFAERS: 3US FAERS
4Drug ineffectiveFAERS: 3US FAERS
5PneumoniaFAERS: 3US FAERS
6Septic ShockFAERS: 3US FAERS
7VomitingFAERS: 3US FAERS
8Bilirubin conjugated increasedFAERS: 2US FAERS
9CholelithiasisFAERS: 2US FAERS
10Disease ProgressionFAERS: 2US FAERS
11Escherichia test positiveFAERS: 2US FAERS
12HepatomegalyFAERS: 230273964CTD
US FAERS
13Lip swellingFAERS: 2US FAERS
14NasopharyngitisFAERS: 2US FAERS
15Abdominal rigidityFAERS: 1US FAERS
16Alanine Aminotransferase IncreasedFAERS: 1US FAERS
17AlopeciaFAERS: 1US FAERS
18Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
19AtaxiaFAERS: 1US FAERS
20Blood glucose decreasedFAERS: 1US FAERS
21CryingFAERS: 1US FAERS
22DisorientationFAERS: 1US FAERS
23DizzinessFAERS: 1US FAERS
24Drug dose omissionFAERS: 1US FAERS
25Feeding intoleranceFAERS: 1US FAERS
26Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
27Gastric infectionFAERS: 1US FAERS
28GastritisFAERS: 1US FAERS
29GastroenteritisFAERS: 1US FAERS
30Hospice CareFAERS: 1US FAERS
31HyperchlorhydriaFAERS: 1US FAERS
32HypersensitivityFAERS: 1US FAERS
33Inappropriate schedule of product administrationFAERS: 1US FAERS
34Infantile spitting upFAERS: 1US FAERS
35InfluenzaFAERS: 1US FAERS
36Iron deficiencyFAERS: 1US FAERS
37Irritable Bowel SyndromeFAERS: 1US FAERS
38MalaiseFAERS: 1US FAERS
39Memory impairmentFAERS: 1US FAERS
40PainFAERS: 1US FAERS
41Portal hypertensive gastropathyFAERS: 1US FAERS
42Prescribed underdoseFAERS: 1US FAERS
43Product dose omissionFAERS: 1US FAERS
44Respiratory FailureFAERS: 1US FAERS
45RestlessnessFAERS: 1US FAERS
46Seizure like phenomenaFAERS: 1US FAERS
47SomnolenceFAERS: 1US FAERS
48TachycardiaFAERS: 1US FAERS
49Transaminases increasedFAERS: 1US FAERS
50TremorFAERS: 1US FAERS
51Vascular access site occlusionFAERS: 1US FAERS
52jaundiceFAERS: 1US FAERS
53Atherosclerosis

View details

CTD
54Cardiomegaly25218494CTD
55Cardiomyopathies25381951CTD
56Chemical and Drug Induced Liver Injury

View details

CTD
57Colonic Neoplasms18444174CTD
58Endomyocardial Fibrosis26004525CTD
59Fatty Liver25218494CTD
60Liver Cirrhosis26004525CTD
61Liver Neoplasms, Experimental6150873CTD
62Liver diseases8698195
25344563
CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.